Cargando…
Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions
Three therapeutic alternatives for prevention of stroke in patients with atrial fibrillation are available in dabigatran (an oral direct thrombin inhibitor), rivaroxaban, and apixaban (both oral blood coagulation factor Xa inhibitors). Compared with warfarin, these new agents have a more predictable...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Just Medical Media Limited
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884849/ https://www.ncbi.nlm.nih.gov/pubmed/24432039 http://dx.doi.org/10.7573/dic.212251 |